Search
for
Sort by
Research 121–150 of 695
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- INDIVIDUAL ARTICLE: Insights on the Impact of Scalp Barrier Condition on Hair Health
- Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review
- Picking a Side: Preferential Laterality in Scalp Hair Density
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- The Challenge of Regrowing Hair With Lasers in Androgenetic Alopecia
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- 43399 Growing uses of PRP: an evaluation of hair growth in cicatricial alopecia
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Alopecia areata clinical trial enrollment and retention outcome factors among underrepresented ethnic and racial groups: A cross-sectional study
- Commonly associated disorders with complete scalp alopecia in early childhood: A review
- Melatonin and the Human Hair Follicle
- IS AGE MORE THAN JUST A NUMBER? CHARACTERISTICS OF MEN PRESENTING FOR REPRODUCTIVE UROLOGY FERTILITY EVALUATION IN NORTH AMERICA STRATIFIED BY AGE GROUPS
- 25560 Assessment of patient satisfaction and adverse effects following the use of a commercially available hair fiber filler
- 28647 Rice products in hair growth
- Clinical Role of Oral Vitamin C and E Therapy in Skin and Hair Disorders
- Using qualitative methods to establish the clinically meaningful threshold for treatment success for the Severity of Alopecia Tool (SALT) score
- PRP for Scarring Alopecia
- 616 Updates in therapeutics for pediatric alopecia areata: A systematic review with evidence-based analysis
- Elucidating the role of the skin and gut microbiome in the development and pathogenesis of alopecia areata
- Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy (Conference Presentation)